Autophagy is a catabolic pathway in which normal or dysfunctional cellular components that accumulate during growth and differentiation are degraded via the lysosome and are recycled. During autophagy, cytoplasmic LC3 protein is lipidated and recruited to the autophagosomal membranes. The autophagosome then fuses with the lysosome to form the autolysosome, where the breakdown of the autophagosome vesicle and its contents occurs. The ubiquitin-associated protein p62, which binds to LC3, is also used to monitor autophagic flux. Cells undergoing autophagy should demonstrate the co-localization of p62, LC3, and lysosomal markers. Immunofluorescence microscopy has been used to visually identify LC3 puncta, p62, and/or lysosomes on a per-cell basis. However, an objective and statistically rigorous assessment can be difficult to obtain. To overcome these problems, multispectral imaging flow cytometry was used along with an analytical feature that compares the bright detail images from three autophagy markers (LC3, p62 and lysosomal LAMP1) and quantifies their co-localization, in combination with LC3 spot counting to measure autophagy in an objective, quantitative, and statistically robust manner.
Introduction
Macroautophagy, hereafter referred to as autophagy, is a catabolic pathway in which damaged or dysfunctional components, long-lived proteins, and organelles are degraded via the lysosome and are recycled 1 . Autophagy is a dynamic, multistep process that involves the formation of an autophagosome; the fusion of the autophagosome with the lysosome, forming the autolysosome; and the degradation of the contents of the autolysosome 2 . The crucial biological marker used to identify autophagy in mammalian systems is the microtubule-associated protein 1A/1B-light chain 3 (LC3), which makes up the autophagosomal membrane. During autophagy, cytosolic LC3-1 is conjugated to phosphatidylethanolamine to form LC3-II; LC3-II is then incorporated into the autophagosomal membrane 3 . Another widely used marker for autophagic flux is the autophagy receptor sequestosome 1 (SQSTM1, p62) which physically links autophagic cargo to the autophagic membrane 4, 5 .
Methods that have traditionally been used to measure autophagy are Western blots and fluorescence microscopy 7 . However, neither of these methods are considered to be the "gold standard," 2, 6 as there are challenges associated with both of these techniques. Western blots only
give an average because they use a homogenate sample, so observers cannot see what is happening in individual cells. On the other hand, fluorescence microscopy gives an observer information at the single-cell level, but it lacks throughput capabilities, making it difficult to obtain objective and statistically rigorous assessments. In recent years, the measurement of LC3 and p62 by multispectral imaging flow cytometry (MIFC, see the Table of Materials) has been gaining popularity due to its quantitative power, high throughput capabilities, multiplexing potential, and ability to image every cell. One of the most widely used methods to measure autophagy using MIFC, along with its companion analysis software (see the Table of Materials) , is through the spot counting of LC3 puncta or autophagosomes 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 . However, an increase in autophagosomes does not necessarily mean that there is an increase in autophagy, as it could also represent a blockade in the process 2 . LC3-II turnover is a useful parameter to measure autophagic flux by analyzing cells in the presence and absence of a lysosomal degradation inhibitor, such as chloroquine. Chloroquine inhibits the fusion of the autophagosome to the lysosome, thereby permitting the quantitation of the autophagosome formation as a measure of the degree of autophagy by arresting autophagic flux before the lysosomal degradation can occur 18 . In addition, p62 is degraded primarily by autophagy, and if the lysosomal degradation of the autophagosome and its contents is blocked, an accumulation of p62 is expected 17, 19 .
Autophagy is a multistep process, and the measurement of LC3 or p62 alone does not provide a complete picture of what is happening in the cells. Recent publications have emphasized the need to examine the concurrent formation of the autolysosome 2, 17, 20, 21 . MIFC is uniquely able to measure the formation of the autolysosome by imaging the co-localization of the autophagosome to the lysosome [15] [16] [17] 20, 21, 22, 23, 24, 25, 26 . In addition, the co-localization of p62 and LC3 using MIFC has also been explored to measure autophagic flux 5 . In the referenced analysis 26, 27 . BDS alone may not be sufficient; Rajan et al. found that using only BDS could lead to false-positive or false-negative results 21 . BDS evaluates the colocalization of two markers of autophagy but does not consider the number of autophagosomes. To account for the number of autophagosomes, Rajan et al. included spot-counting of the LC3 puncta 21 . Rajan et al. proposed using a bivariate scatter plot of LC3 spot count versus BDS. Using this bivariate plot, two populations were first identified: one with cells that have a high level of LC3 spots and one with cells that have a low level of LC3 spots. The high-LC3 spot population was further classified into two populations: cells with low co-localization (i.e., accumulation of autophagosomes) and cells with high co-localization (i.e., accumulation of autolysosomes). This bivariate plot allows one to distinguish between cells with very few autophagosomes and cells with an accumulation of autophagosomes and/or autolysosomes 21 .
Until now, the simultaneous co-localization of LC3, p62, and LAMP1 (lysosomal marker) was not possible using a single "Feature Type" in the MIFC companion analysis software (see the Table of Materials) . However, a new feature, recently introduced in version 6.1, is called Bright Detail Colocalization 3 (BDC3). BDC3 compares the bright detail images from each of the three images (in this case, LC3, p62, and LAMP1) and quantifies the co-localization of the three probes (i.e., LC3, p62, and LAMP1). The BDC3 feature computes the Pearson's correlation coefficient modified to extend to three images. Since the bright spots in the three images are either correlated or uncorrelated, the correlation coefficient varies between 0 (uncorrelated) and 1 (perfect correlation). The coefficient is log-transformed to increase the dynamic range between 0 and infinity. By switching out the BDS feature with the BDC3 feature, the analysis method presented by Rajan et al. can now incorporate the three most-used markers to measure autophagy in one system at the same time. The ability to co-localize these three markers of autophagy in a single assay could lead to novel insights into the induction and regulation of autophagy. The following protocol outlines the steps to induce autophagy in Jurkat cells; label the cells with LC3, p62, and LAMP1 antibodies; acquire data on a multispectral imaging flow cytometer; and analyze the data to assess autophagic flux. 2. Add 100 µL of 4% formalin fixation solution to each of the cell pellets. Resuspend by pipetting up and down with a P200 pipette. Incubate for 10 min at room temperature. During the fixation step, transfer the samples to labeled, siliconized polypropylene microcentrifuge tubes. NOTE: Do not over-fix the cells; this might result in poor labeling results. 3. After the 10 min fixation step, add 1 mL of wash buffer to each sample. Pipette up and down with a P1000 pipette to mix the sample.
Centrifuge at 250 x g for 5 min. Aspirate off the supernatant. 4. Add 100 µL of anti-SQSTM1/p62 -AF488 antibody/permeabilization buffer working solution to each sample. Resuspend by pipetting up and down with a P200 pipette. Incubate for 30 min in the dark at room temperature. 5. Wash the cells by adding 1 mL of permeabilization buffer to each sample. Pipette up and down with a P1000 pipette to mix the sample.
Centrifuge at 250 x g for 5 min. Aspirate off the supernatant. 6. Repeat steps 5.4-5.5 for each of the antibody working solutions. NOTE: The antibody working solutions are mouse anti-LC3/permeabilization buffer working solution, donkey anti-mouse -AF647/ permeabilization buffer working solution, and anti-human CD107a (LAMP1) -PE antibody/permeabilization buffer working solution. Each antibody should be done separately and in the listed order. The order was chosen to minimize unwanted cross-reactivity between antibodies. 7. Add 100 µL of 1% formalin solution. Resuspend by pipetting up and down with a P200 pipette. Add 10 µL of the 10x DAPI nuclear stain to each sample. Lightly vortex each sample to mix. Incubate for 10 min in the dark at room temperature before running any of the samples on the instrument. NOTE: At this point, the sample can either be run on the MIFC or stored protected from light at 2-8 °C for up to a week.
Labeling of Single-color Controls
1. For each single-color control (i.e., AF488, PE, AF647, and DAPI), take 1 x 10 6 Jurkat cells, which can be from any of the sample populations.
Put 1 x 10 6 cells in 15 mL centrifuge tubes labeled as either AF488, PE, AF647, or DAPI.
2. Add wash buffer so that there is a total volume of 15 mL in each 15 mL centrifuge tube. Centrifuge the samples at 250 x g for 10 min. Aspirate off the supernatant. 3. Add 100 µL of wash buffer to the AF488, PE, and AF647 tubes. NOTE: For the DAPI tube, go to step 6.8. 1. Resuspend by pipetting up and down with a P200 pipette. Transfer to 1.5-mL tubes.
4. Add 5 µL of either anti-CD45-AF488, anti-CD45-PE or anti-CD45-AF647 to the AF488, PE, or AF647 tubes, respectively. Mix by vortexing lightly. 5. Incubate the AF488, PE, and AF647 tubes for 30 min in the dark at room temperature.
NOTE: Other markers can be used, such as LC3, p62, and LAMP-1 antibodies instead of anti-CD45 antibodies. However, CD45 is a reliable marker for single-color controls. 6. Wash the AF488, PE, and AF647 cells by adding 1 mL of wash buffer to each sample.
1. Pipette up and down with a P1000 pipette to mix the sample. Centrifuge at 250 x g for 5 min. Aspirate off the supernatant.
7. Add 100 µL of 1% formalin solution. Resuspend by pipetting up and down with a P200 pipette. NOTE: At this point, the sample can either be run on the MIFC or stored protected from light at 2-8 °C for up to a week. 8. Add 100 µL of 1% formalin fixation solution to the DAPI tube.
1. Resuspend by pipetting up and down with a P200 pipette. Incubate for 30 min at room temperature. 2. Add 10 µL of 10x DAPI nuclear stain to the DAPI sample. Lightly vortex to mix. Incubate for 10 min in the dark at room temperature prior to running on the instrument. NOTE: At this point, the sample can either be run on the MIFC or stored protected from light at 2-8 °C for up to a week.
Starting and Calibrating the MIFC
1. Check to make sure the sheath, system calibration reagent (see the Figure 1 . NOTE: For this experiment, the laser powers are 200 mW, 20 mW, 150 mW, and 5 mW (Ch06) for the 488 nm, 405 nm, 642 nm, and SSC, respectively. The MIFC default template magnification it set to 40X, the default sensitivity is Hi, and all channels are enabled. 3. Confirm that the magnification slider is set to 40X, high-sensitivity mode is selected, and all channels are showing in the image gallery; Figure 1 shows the instruments settings used in this experiment. 4. Load the "Starved + Chloroquine" sample by clicking on the Load button and loading the 1.5 mL tube onto the instrument.
NOTE: This experimental sample should have the highest signal of all samples for AF488, PE, and AF647 (the DAPI signal should have approximately the same signal strength for all experimental samples, including the "Starved + Chloroquine" sample). 5. Use the "Starved + Chloroquine" sample to confirm that the appropriate laser powers for the 488 nm, 405 nm, 642 nm, and SSC lasers are set. Use the raw max pixel dot plots from the default template to adjust the laser powers so that the signals are strong but do not reach a raw max pixel value of 4,096, which would saturate the CCD camera on the instrument. Use this laser setting for all experimental samples. 6. Click on the Create Dot Plots icon to create a new dot plot. Select "Area_M01" on the X-axis and "Aspect Ratio_M01" on the Y-axis for the "all" population. Click on the Create Polygon Region icon. Draw a region around the cells. Name this region "Cell." NOTE: Users can add additional plots and regions to narrow down the cells being collected. A common additional plot to add would be Gradient RMS to identify cells that are in focus. 7. Set the acquisition parameters. Specify the file name and destination folder, change the number of events to "5,000," and select the "Cell" collection population. Click the Acquire button to acquire the file. After collecting the file, return the sample by clicking the Return button. Remove the sample tube from the instrument. 8. For the next three samples ("Starved," "Control," and "Control + Chloroquine"), load the sample, enter the sample name, acquire the sample, and return the sample using the same settings as for the "Starved + Chloroquine" sample, above. 9. After the samples have been acquired, run the single-color control samples and acquire data so that a compensation matrix can be made.
Turn off the SSC laser by clicking on the SSC button. Turn off the brightfield channels by clicking on the Brightfield button and selecting OFF. NOTE: If channels were removed from the image gallery for experimental sample acquisition, re-enable all channels. Alternatively, singlecolor controls can be acquired by clicking on the Compensation tab and selecting Create Matrix; this opens the compensation wizard, which will walk through the step of collecting files and making a compensation matrix. 10. Load the DAPI single-color control by clicking on the Load button and loading the 1.5 mL tube into the instrument. Enter the sample name (DAPI only), set the collection population to "All," and change the number of events to "500." 1. Click the Acquire button to acquire the single-color control file. 2. When the file collection is complete, return the sample by clicking the Return button. Remove the sample tube from the instrument. 3. After the DAPI sample, load 10% bleach just like a sample by clicking on the Load button and loading 100 µL of 10% bleach in a 1.5 mL tube. Let the sample run for ~15 s. This will remove any residual DAPI from the tube. 4. Run 100 µL of 1x PBS, as done in 8.10.3, to remove the residual 10% bleach. The instrument is now ready to run the AF488, PE, and AF647 single-color controls. 5. Repeat steps 8.10-8.10.2 for each of the single-color controls (i.e., AF488, PE, and AF647).
NOTE: There is no need to run 10% bleach or PBS between these samples, only after the DAPI single-color control. 
Data Analysis in the MIFC Analysis Software

Representative Results
This analysis method uses multiple features to asses autophagic flux. In order to fully understand the final bivariate plot, the individual analysis features must first be investigated. The counting of autophagosomes is a logical way to measure autophagy; however, the size/shape/brightness of LC3 puncta can vary drastically between cells. Variation can make it difficult to count autophagosomes manually or using a spot-count feature in the analysis software. Therefore, no spot-count feature will be perfect due to this large variability in autophagosomes. However, a good spotcount feature will work on most cells 26 . Figure 3 shows examples of spot masking of LC3 puncta in Jurkat cells using different spot masks. The spot-count feature selected for this data set is Spot Count_Peak(M11, Ch11-LC3-AF647, Bright, 4)_4, meaning that the spot-count feature counted the spots that the peak mask identified within the default channel 11 mask (M11) on channel 11 (Ch11-LC3-AF647) with a spot-to-cell background ratio of 4 (Bright, 4). Figure 4 shows spot-count histograms and representative images for the mean spot count for the Control, Control + Chloroquine, Starved, and Starved + Chloroquine Jurkat cells labeled with anti-LC3-AF647. The Control and Starved mean spot counts are not significantly different; with the addition of chloroquine, there is a large difference in the mean of the Control + Chloroquine compared to the Starved + Chloroquine.
The next feature to investigate is BDC3. BDC3 is a measurement of the co-localization of three markers/probes, in this case, LC3, p62, and LAMP1. Figure 5A-5D shows BDC3 histograms for the Control, Control + Chloroquine, Starved, and Starved + Chloroquine Jurkat cells labeled with anti-p62-AF488, anti-LAMP1-PE, and anti-LC3-AF647. There is a shift between the Control mean to the Starved mean, as well as the Control + Chloroquine mean to the Starved + Chloroquine mean. However, looking at the images of cells from the mean BDC3 scores in Figure  5E -5H, there is a greater difference between the samples than the histograms may lead one to believe. This is because BDC3 does not consider the number of autophagy organelles that co-localize, resulting in a large degree of variability in the number of autophagosomes for the same BDC3 score. In most cases, there is overlap between all three probes because, even at basal levels, p62, LAMP1, and LC3 should, to a certain extent, co-localize or reside in similar regions in the cells. As a contrast, an example of three probes that should not co-localize are anti-p62-AF488, anti-LC3-AF647, and DAPI nuclear dye for the Starved + Chloroquine sample, shown in Figure 6 .
When the spot-count feature and the BDC3 feature are combined, the presence of different subpopulations that improve the ability to distinguish between the various samples/conditions are evident. Figure 7 shows the bivariate plot of spot count of LC3 versus BDC3 p62/LAMP1/LC3 for the four samples: Control, Control + Chloroquine, Starved, and Starved + Chloroquine. The Control sample was used to set the gating strategy for three populations: Low Spots, High Spots/Low BDC3, and High Spots/High BDC3. The Control samples demonstrated that greater than 98% of the cells had 1 or fewer spots. The boundary between the High Spots/Low BDC3 and High Spots/High BDC3 was set to a BDC3 score of 1 because more than 91% of the Control sample had a BDC3 score of less than 1. A summary of the results for the bivariate plots is shown in Like BDS, which has been previously reported 15, 16, 17, 20, 21, 22, 23, 24, 25, 26 , BDC3 alone does not take into account the number of autophagy organelles that co-localize, resulting in a large degree of variability in the number of autophagosomes. Therefore, the bivariate approach presented by Rajan et al. was employed. Looking at the bivariate plots, one might ask if the cells must be positive for LC3, p62, and LAMP1; why are there so many cells that have 0 spots? This is because the LC3 signal might be bright enough for co-localization, but it might not meet the threshold set by the peak mask (Peak (M11, Ch11-LC3-AF647, Bright, 4)) necessary for it to be considered a spot.
The protocol presented here used MIFC to count LC3 puncta and the co-localization of three autophagy markers to measure autophagic flux. Under basal conditions (Control sample), the number of autophagosomes was low, and few cells were found with "High Spots." With the addition of chloroquine, which inhibits autophagosome/lysosome fusion, there was an increase in the number of LC3 spots. Since the lysosome is unable to break down the autophagosome and the p62, which resides in the autophagosome, this leads to an increase in the co-localization of the LC3, p62, and LAMP1 autolysosome accumulation. This effect was amplified under nutrient starvation, which induces autophagy. However, without the addition of chloroquine, there was not a significant increase in the number of autophagosomes, most likely due to an increase in the rate of autophagic turnover. When cells were starved in the presence of chloroquine, there was an increase in the co-localization and number of autophagosomes, which supports the conclusion that starvation increases autophagic flux. EBSS is known to be a powerful inducer of autophagy. Therefore, it is expected that the increase would be large. If another method, such as drug induction, is used to induce autophagy, the difference between the control and treated samples may be subtler.
This particular protocol was designed to measure autophagy in human cell lines, but the assay could be adapted to other species by switching to antibodies for that particular species. In addition, the analysis method could be used for any intracellular application that requires the colocalization of three probes/markers.
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